Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance
- 20 August 2019
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 12 (595)
- https://doi.org/10.1126/scisignal.aas8779
Abstract
Metastable phenotypic state transitions in cancer cells can lead to the development of transient adaptive resistance or tolerance to chemotherapy. Here, we report that the acquisition of a phenotype marked by increased abundance of CD44 (CD44Hi) by breast cancer cells as a tolerance response to routinely used cytotoxic drugs, such as taxanes, activated a metabolic switch that conferred tolerance against unrelated standard-of-care chemotherapeutic agents, such as anthracyclines. We characterized the sequence of molecular events that connected the induced CD44Hi phenotype to increased activity of both the glycolytic and oxidative pathways and glucose flux through the pentose phosphate pathway (PPP). When given in a specific order, a combination of taxanes, anthracyclines, and inhibitors of glucose-6-phosphate dehydrogenase (G6PD), an enzyme involved in glucose metabolism, improved survival in mouse models of breast cancer. The same sequence of the three-drug combination reduced the viability of patient breast tumor samples in an explant system. Our findings highlight a convergence between phenotypic and metabolic state transitions that confers a survival advantage to cancer cells against clinically used drug combinations. Pharmacologically targeting this convergence could overcome cross-drug tolerance and could emerge as a new paradigm in the treatment of cancer.Keywords
Funding Information
- National Institutes of Health (1U01CA214411)
- American Cancer Society (122854-PF-12-226-01-CDD)
- Breast Cancer Alliance (Young Investigator Award)
- the Natural Sciences and Engineering Research Council of Canada (Discovery Grant)
This publication has 78 references indexed in Scilit:
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant ResponsesScience, 2011
- Cross talk between mitochondria and NADPH oxidasesFree Radical Biology & Medicine, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Metabolism and proliferation share common regulatory pathways in cancer cellsOncogene, 2010
- Structural Basis for CD44 Recognition by ERM ProteinsOnline Journal of Public Health Informatics, 2008
- Brick by brick: metabolism and tumor cell growthCurrent Opinion in Genetics & Development, 2008
- Cytokine Stimulation Promotes Glucose Uptake via Phosphatidylinositol-3 Kinase/Akt Regulation of Glut1 Activity and TraffickingMolecular Biology of the Cell, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- On the Origin of Cancer CellsScience, 1956